Preclinical Imaging Market Size to Hit USD 5.48 Billion by 2030 at 3.20% CAGR – Report by Market Research Future (MRFR)

According to a Comprehensive Research Report by Market Research Future (MRFR), “Preclinical Imaging Market Information By Product, Distribution Channel, And Region – Forecast till 2030“, the market size was valued at USD 4.4 billion in 2022 and is projected to grow from USD 4.54 Billion in 2023 to USD 5.48 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 3.20% during the forecast period (2023 – 2030)

Market Scope

Preclinical imaging represents living organisms for scientific studies such as drug development. Imaging techniques have long been essential to researchers to observe animal modifications in reaction to biological or environmental alterations, whether at the tissue, organs, cell, or molecular level. The importance of non-intrusive and in vivo imaging techniques has increased for long-term studies using animal models. The practice of modern medicine and the management of health issues are impacted by translational research. Small animals are essential to these studies and development initiatives in fundamental and preclinical sciences as a bridge between molecular advances and clinical use in diagnostics and therapeutics. The most recent advancements in high-frequency ultrasound technology have also been researched about the future.

Get Free Sample PDF Brochure @ https://www.marketresearchfuture.com/sample_request/7365

It will be easier for researchers to comprehend living animals’ cellular, molecular, and bodily modifications and forecast how new treatments will work on patients thanks to multiple imaging techniques in preclinical studies. Additionally, as there are more clinical research companies and drug companies, in-vivo imaging systems are being used more frequently in preclinical research, which is predicted further to fuel the market’s expansion for preclinical imaging. As a result, more and more people are adopting alternative approaches like in-vitro testing, micro-dosing, computer-based designs, virtual drug testing, and the creation of computerized records for testing. However, non-invasive imaging modalities like MRI and C.T. scans are gaining popularity. Multimodal molecular imaging may soon enable pre-symptomatic detection, specific treatment, and customized healthcare due to the rapid advancement of technology. Preclinical micro-ultrasound is investigated for cardiovascular disease, cancer, and developmental biology.

Report Scope:

Report AttributeDetails
Market Size in 2030USD 5.48 Billion
CAGR3.20%
Base Year2022
Forecast Period2023-2030
Historical Data2021
Forecast UnitsValue (USD Billion)
Report CoverageRevenue Forecast, Competitive Landscape, Growth Factors, and Trends
Segments CoveredBy Product And Distribution Channel
Geographies CoveredNorth America, Europe, Asia-Pacific, and Rest of the World (RoW)
Key Market DriversIncreased demand for certified Preclinical Imaging products to propel market growth
Growing use of preclinical imaging is one of the key factors boosting the market revenue globally

Preclinical Imaging Market Competitive Landscape:

The leaders in the market of preclinical imaging are:

  • Bruker Corporation (U.S.)
  • Mediso Ltd. (Hungary)
  • Miltenyi Biotec GmbH (Germany)
  • LI-COR Inc. (U.S.)
  • Aspect Imaging (Israel)
  • Trifoil Imaging (U.S.)
  • M.R. Solutions (U.K.)
  • PerkinElmer (U.S.)
  • Fujifilm Holdings Corporation (Japan)
  • Milabs B.V. (The Netherlands)

Preclinical Imaging Market Trends:

Market Drivers:

The growing importance of the preclinical imaging market is primarily driven by advances in molecular imaging, an uptick in preclinical research funding from public and private organizations and increasing demand for non-invasive small livestock imaging techniques. The market is growing primarily due to increased funding for R&D and investments and the lightning-fast pace of technological advancements that have resulted in the development of hybrid imaging devices. The market is growing primarily due to increased R&D funding and investments and the steady pace of scientific advancements that have resulted in the development of hybrid imaging devices. Preclinical research is revolutionizing how people are treated and how modern medicine is practiced, resolving several health issues.

    Written by

    Market Research Future

    Market Research Future (MRFR) is a global market research company that takes pride in its services, offering a complete and accurate analysis regarding diverse markets and consumers worldwide. Market Research Future has the distinguished objective of providing the optimal quality research and granular research to clients. Our market research studies by products, services, technologies, applications, end users, and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help answer your most important questions.

    Leave a Comment